http://rdf.ncbi.nlm.nih.gov/pubchem/patent/TW-217986-B
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_70a0919564cd6d43eac5a20c7ce430c0 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7068 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K- http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-70 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H19-00 |
| filingDate | 1992-04-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 1993-12-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_048dd3e60bcfc7491b539df7268f0784 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e0f8ea4985c9d223f37ab025821bdfbe http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_96a1556ba74d3774d455aa3e42a6b16a |
| publicationDate | 1993-12-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | TW-217986-B |
| titleOfInvention | Compositions for the treatment of infection and disease caused by HBV |
| abstract | The present invention relates to pharmaceutical compositions useful for the treatment of subjects suffering from an infection or disease caused by the hepatitis B virus (HBV). In particular, it has been discovered that the administration of low dosage amounts of 1-(2'-deoxy-2'-fluoro-beta-D-arabinofuranosyl)-5-iodouracil (FIAU) to humans chronically infected with HBV is effective to reduce drastically circulating markers associated with HBV. The present invention is also directed to methods of the preparation of pharmaceutical antiviral compositions. |
| priorityDate | 1992-04-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 20.